Metabolic Health
SGLT2 Inhibitors May Slow Aging by Clearing Senescent Cells
Diabetes drugs like empagliflozin show surprising anti-aging effects — mimicking caloric restriction and reducing senescent cell burden.
Research Paper
May 15, 2026 0
Topic
Diabetes
Type 1 and type 2 diabetes, insulin resistance, glucose metabolism, and metabolic health
294 articles
Metabolic Health
NIH Spotlights Pancreatic Aging, Heart Risk and Testosterone in Cancer Defense
Three new NIH-funded findings tackle metabolic aging, cardiovascular risk, and a surprising hormonal brake on brain tumors.
Press Release
May 14, 2026 0
Metabolic Health
Recurrent Low Blood Sugar Does Not Rewire Brain Glucose Transport in Type 1 Diabetes
A rigorous MRI-based study finds that repeated hypoglycemia episodes leave brain glucose transport kinetics unchanged, challenging a leading hypothesis.
Research Paper
May 14, 2026 0
Metabolic Health
Gut Device Outperforms Semaglutide for Weight Loss and Insulin Sensitivity in Animal Study
A novel endoluminal device implanted in the gut improved insulin sensitivity and weight control beyond what semaglutide achieved in a pig model.
Research Paper
May 14, 2026 0
Metabolic Health
CGM Devices for Biohackers Ranked by Evidence in 2026
A head-to-head review of 10 CGM devices for healthy adults, weighing real-world accuracy data against limited longevity evidence.
Review
May 13, 2026 0
Metabolic Health
NIH Funds Pancreas Atlas and Heart Risk Models Targeting Age-Related Disease
Three NIH-funded studies this week tackle metabolic decline, cardiac risk, and brain tumors — all with aging implications.
Press Release
May 13, 2026 0
Metabolic Health
Cochrane Review Protocol Sets Stage for Definitive Insulin Regimen Comparison in Type 1 Diabetes
A major Cochrane network meta-analysis protocol will rank all insulin regimens by efficacy and safety for adults with type 1 diabetes.
Research Paper
May 13, 2026 0
Metabolic Health
SGLT2 Inhibitors May Shield Kidneys From Acute Injury Through Multiple Mechanisms
A comprehensive review finds SGLT2 inhibitors reduce AKI risk in humans via hemodynamic, metabolic, and cellular protective pathways.
Research Paper
May 12, 2026 0
Metabolic Health
CGMs for Longevity Seekers: Real Benefits, Real Limits and What the Evidence Actually Shows
Expert reviews of top CGM platforms reveal genuine metabolic insights — but no proof they extend lifespan in healthy adults.
Review
May 12, 2026 0
Metabolic Health
Skin-Worn Microneedle Sensors Track Glucose and Metabolites Without Blood Draws
Wearable microneedle patches tap interstitial fluid to monitor glucose, lactate, and electrolytes in real time — no needles, no lab.
Research Paper
May 11, 2026 0
Metabolic Health
Premium
AMPK's Molecular Playbook: Mechanisms Behind Cellular Energy Sensing
Go deeper into how AMPK detects energy stress, activates upstream kinases, and coordinates metabolism, autophagy, and longevity pathways at the molecular level.
TutorialIntermediate
May 9, 2026 0
Metabolic Health
FDA Approves First Oral GLP-1 Weight Loss Pill Orforglipron
Foundayo (orforglipron) becomes the first oral GLP-1 receptor agonist approved for obesity, offering a pill alternative to injectable Wegovy.
Drug Approval
May 9, 2026 0